Angiotensin II/toxicity; Arteriosclerosis/metabolism; Chemokine CCL2/physiology; Hyperlipoproteinemia Type II/complications; Inflammation Mediators/physiology; Angiotensin II/administration & dosage; Angiotensin II Type 1 Receptor Blockers/pharmacology; Animals; Aortic Diseases/etiology; Aortic Diseases/metabolism; Aortic Diseases/pathology; Apolipoproteins E/deficiency; Apolipoproteins E/genetics; Arteriosclerosis/etiology; Arteriosclerosis/pathology; Chemokines/biosynthesis; Chemokines/genetics; Cytokines/biosynthesis; Cytokines/genetics; Disease Progression; Gene Expression Regulation/drug effects; Gene Targeting; Humans; Imidazoles/pharmacology; Inflammation; Injections, Intramuscular; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Olmesartan Medoxomil; Random Allocation; Recombinant Fusion Proteins/physiology; Sequence Deletion; Single-Blind Method; Tetrazoles/pharmacology